The Food and Drug Administration (FDA) has granted approval for a request made by DreaMed regarding their artificial intelligence-enabled diabetic software, which is exclusively meant for the providers, who are managing Type 1 diabetes patients.
A new robotic system called OSCANN Desk has been developed by researchers at Spain’s Universidad Politécnica de Madrid (UPM) and start-up AURA Innotive Robotics. The system has been designed for the accurate analysis of eye movements in order to detect neurodegenerative diseases such as Parkinson’s disease.
On Wednesday, a day after Keytruda got the thumbs up for cervical cancer, the drug was approved for treatment of a rare form of non-Hodgkins lymphoma patients who cancer returned after at least two previous treatment lines. Last year, Keytruda also got an indication for classical Hodgkin lymphoma.
Malaria is a global health problem, where millions of people are being affected. It is a well-known fact that artemisinin is the only effective anti-malarial drug which is produced from the Chinese medicinal plant Artemisia annua. Currently, the prevailing issue is that the cultivation of Artemisia annua leaves cannot meet the global demand.
U.S. Food and Drug Administration officially approved the weekly injection of semaglutide under the brand name of Ozempic. This therapy along with healthy diet and exercise would improve glycemic control in adults with type 2 diabetes. The side effects of semaglutide was found to be mild or moderate nausea.
They recently announced the SleepScore app which emits imperceptible sound waves as a sonar system from a smartphone. The sound waves reflect off the user’s body and are relayed back to the smartphones’ microphone. SleepScore’s algorithm then calculates the results and provides a sleep metric measured from 0 to 100 for the quality of sleep.
The recent research that achieved the FDA approval for Mircera, had 64 patients, aged between 5 to 17 years old who suffered from chronic kidney disease (CKD) and were on kidney dialysis at the beginning of the study.
It has been reported that the FDA has granted the approval of Mobius Imaging, LLC based Airo CT imaging utilization for pediatric patients. These pediatric patients can receive the clinical benefits of Airo CT imaging for diagnostic and intraoperative procedures hereafter.
The newly launched site will also provide details on the effect that food intake, exercise, and medication can have on control glucose levels along with color-coded graph and charts which are focused at usability, bolus tracking features, amplified insulin pump reports, and statistics.
your submission has already been received.
Please enter a valid Email address！
The most relevant industry news & insight will be sent to you every two weeks.